logo
Plus   Neg
Share
Email

Ams CFO Michael Wachsler To Step Down; Confirms Q1 Outlook

Austrian sensor maker ams said that its Chief Financial Officer Michael Wachsler will step down from his position in the Management Board of the company effective 31 May 2020.

In addition, Ams' Supervisory Board plans to propose that Michael Wachsler be elected as member of the Supervisory Board in the Annual General Meeting 2022 following a two-year cooling-off period.

Meanwhile, ams has appointed Ingo Bank as its Chief Financial Officer, effective 1 May 2020. Ingo Bank's term will run for three years.

Ingo Bank will step down from the Management Board of Osram Licht AG, where he holds the CFO position, effective 30 April 2020.

Separately, ams said it assessed the Covid-19 situation in relation to the company' business which has not resulted in a change to expectations for the first quarter.

ams confirmed financial expectations for the first quarter 2020 with revenues of $480 million- $520 million and an expected adjusted operating (EBIT) margin of 19-21%.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Zoom Video Communications (ZM) gained 4% on extended session Tuesday after the video conferencing software company reported a first-quarter results that trumped Wall Street estimates and issued a outlook for the second and full year 2021 that is expected to beat current expectations. First-quarter... The National Retail Federation Chief Economist Jack Kleinhenz said it was too early to say how quickly or smoothly the U.S. economy would stage a recovery following the "sizable disruptions" due to the coronavirus pandemic. However, he noted that the reopening of businesses and the resumption of economic activity is a significant step forward. Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products.
Follow RTT